Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Nov 17, 2015
    AMA Calls for Ban on DTC Ads
  • Nov 13, 2015
    Court Issues Temporary Restraining Order Against Making Generic Nexium Purple
  • Nov 9, 2015
    FDA Web Page Flags Fraudulent Marketing for Serious Diseases
  • Nov 5, 2015
    POM Wonderful Asks Supreme Court To Consider FTC Case
  • Nov 4, 2015
    Canadian Study Finds Rate of Adverse Events Higher for Off-label Use of Drugs
  • Nov 3, 2015
    OMB Approves OPDP DTC Ad Study
  • Oct 29, 2015
    Warner Chilcott Settles Charges Stemming from Kickbacks, HIPAA Violations for $125 Million
  • Oct 28, 2015
    Novartis Sets Aside $400 Million to Settle Federal Specialty Pharmacy Case
  • Oct 14, 2015
    Relator Must Wait for Appeal on Whether Fraud on the FDA Can Lead to False Claims Liability
  • Oct 12, 2015
    CDRH Concerned Review Commitments Are Not Being Kept
  • More

Good Clinical Practice

  • Oct 29, 2016
    SACHRP Develops Flow Chart, Recommendations for Federal Regulation of Cluster Randomized Trials
  • Oct 28, 2016
    SACHRP Develops Points to Consider on Single IRB Review
  • Oct 28, 2016
    IRB Written Procedure Guidance Needs More Clarity
  • Oct 27, 2016
    SACHRP Gets Ready for Common Rule Revision By Clearing Its Backlog
  • Oct 24, 2016
    NBME Starts Clinical Research Certification Program
  • Oct 24, 2016
    Checklist of Study Core Outcome Sets Developed
  • Oct 20, 2016
    EMA Starts Posting Clinical Reports
  • Oct 19, 2016
    Few Firms Post Compassionate Use Policies
  • Oct 18, 2016
    NMQF Develops Maps Detailing Cancer Prevalence by Key Factors
  • Oct 18, 2016
    OpenTrials Database Launches Beta Version
  • More

FDA Regulation & Enforcement

  • May 1, 2019
    FDA Seeks Input on Cannabis as Food, Supplement Ingredient
  • May 1, 2019
    AMS Makes Changes to National List
  • May 1, 2019
    FSIS Proposes To Amend Dual Content Regulations
  • Apr 29, 2019
    Grassley, Wyden Question Physician-Owned Distributorships’ Compliance with Sunshine Act Reporting Mandates
  • Apr 29, 2019
    Two Drug Companies To Pay $125 Million To Resolve Kickback Allegations Involving Co-pay Assistance
  • Apr 26, 2019
    Connecticut Files Amended Lawsuit Against Purdue Pharma
  • Apr 25, 2019
    FDA Modifies Mandatory Labeling Declaration for Allulose
  • Apr 24, 2019
    Draft FDA Guidance Shows How Companies Should Prepare for, Initiate Voluntary Product Recalls
  • Apr 23, 2019
    J&J To Pay $9.9 Million To Settle Washington Suit Over Disclosure of Surgical Mesh Risks
  • Apr 22, 2019
    OPDP-RTI Review of DTC Studies Finds Both Potential Benefits and Harms
  • More

Medical Devices

  • Jan 31, 2011
    FDA Identifies 19 Steps To Improve Center Transparency
  • Jan 31, 2011
    Parallel Reviews Must Be Voluntary, AdvaMed Says
  • Jan 31, 2011
    IDE Review Longer Than Reported, Survey Finds
  • Jan 31, 2011
    Exactech Enters Into DPA Over Kickback Allegations
  • Dec 31, 2010
    Synthes, Norian Plead Guilty for Alleged Involvement in Conducting Unauthorized Trials
  • Dec 31, 2010
    FDA, Health Canada Say Joint Agency Audits Work
  • Dec 31, 2010
    CDRH To Issue Plan for 510(k) Program Changes
  • Dec 31, 2010
    California Appeals Court Says Federal Law Preempts State Claims Arising From Device Clinical Trials
  • Dec 31, 2010
    IOM Panel: Incentives Needed for HDE Development
  • Dec 31, 2010
    FDA Concerned About External Defibrillator Safety
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.